Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2012; 18(17): 2112-2120
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2112
Table 3 Adjusted odds ratios for gastric cancer associated with NOD1 and NOD2 polymorphisms
GenersIDChr1121GC groupGA groupAOR2 (95% CI)
HeterozygoteHomozygoteDominantRecessive
11/12/2211/12/22
NOD1rs171590487GT1/62/2333/38/11830.82 (0.52-1.31)/0.78 (0.49-1.22)/
rs29077497GA23/117/15622/62/760.92 (0.61-1.39)0.50 (0.26-0.95)a0.81 (0.55-1.19)0.52 (0.28-0.96)a
rs20758207AG32/118/145312/78/6830.70 (0.47-1.06)1.27 (0.62-2.64)0.78 (0.53-1.16)1.51 (0.75-3.04)
rs77890457TA65/126/10521/67/721.30 (0.85-1.99)2.14 (1.20-3.82)a1.50 (1.01-2.22)a1.87 (1.09-3.20)a
NOD2rs206708516GC0/46/2500/24/1361.04 (0.61-1.78)///
rs186175916CA8/69/2193/43/1140.79 (0.50-1.23)1.29 (0.33-4.97)0.82 (0.53-1.27)/
rs313550016AG16/111/16912/51/971.22 (0.80-1.85)0.73 (0.33-1.61)1.13 (0.76-1.67)0.68 (0.31-1.47)
rs720542316GC20/135/14114/61/851.31 (0.87-1.96)0.82 (0.39-1.72)1.22 (0.82-1.79)0.72 (0.35-1.48)